跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 59,455 条关于
“NK-cell lymphoma”
全部
59,455
临床试验
42,334
药物
4,722
机构
139
资讯
12,260
去年
Antengene to Present Selinexor Data in Relapsed/Refractory Multiple Myeloma and Extranodal NK/T-Cell Lymphoma at ASH 2024
2年前
Kymera's KT-333 Demonstrates Antitumor Activity in Hematological Cancers in Phase 1 Trial
去年
Antengene's Selinexor Shows Promise in Multiple Myeloma and Lymphoma Studies
去年
Antengene to Present Selinexor Data from Late-Stage Trials at ASH 2024
去年
Antengene to Present Selinexor Data from Phase III Multiple Myeloma and Phase I/II Lymphoma Studies at ASH 2024
11个月前
DNMT Inhibitors Combined with Anti-PD-1 Therapy Show Promise for Refractory NK/T-Cell Lymphoma
去年
T-Cell Malignancy Pipeline Shows Promise with Novel Therapies and Approvals
去年
Antengene to Present Selinexor Data from Two Late-Stage Studies at ASH 2024
去年
Innovative NK Cell Engagers Show Promise in Lymphoma Treatment
去年
Emercell Receives EMA Approval to Study Allogeneic NK Cell Therapy for Diffuse Large B-Cell Lymphoma
第 1 页,共 1226 页
上一页
下一页